Quantum biopharma announces intention to declare special dividend of contingent value rights (cvrs) linked to future litigation settlement proceeds

Toronto, june 13, 2025 (globe newswire) -- quantum biopharma ltd. (nasdaq: qntm) (cse: qntm) (fra: 0k91) (“quantum biopharma” or the “company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is pleased to announce its intention to declare a special dividend consisting of contingent value rights (the “cvrs”) to be issued on a 1:1 basis to holders of the company's class b subordinate voting shares.
QNTM Ratings Summary
QNTM Quant Ranking